RxMen is a full-stack, clinic-led men’s health platform that focuses on root-cause treatment across sexual health, hormones, skin, stress, and sleep. The company has developed a Sexual Health Index (SHI) built from 25,000 anonymized consultations and reports a 95% success rate based on SHI outcomes; the index is now under validation at IIT Jodhpur. Over the past 20 months RxMen says it has grown 100x in revenue, has delivered over 30,000 consultations, and is handling about 6,000 consultations monthly via a network of 30 specialists. RxMen reported MRR of $70,000 (Aug 2025) and projects an ARR of $1.7 million by FY26. The firm plans to use new proceeds for brand building, launching RxMen-branded products, and setting up co-branded clinics, and targets achieving positive EBITDA by October 2025. It competes with incumbents such as Man Matters (Mosaic Wellness), Bold Care, and Traya.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2025